Mustang Bio, Inc. SEC filings MBIO

Mustang Bio, Inc. has 405 filings in SEC EDGAR's recent list, going back to Jul 28, 2016. Its latest annual report, Form 10-K, was filed on Mar 19, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 15, 2026 (other events). The company's fiscal year ends on December 31.

Mustang Bio, Inc. SEC filings
Form Description Filed Period
4 Insider transaction Apr 27, 2026 Apr 24, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Jan 5, 2026 —
4 Insider transaction Jan 5, 2026 Jan 2, 2026
4 Insider transaction Dec 30, 2025 Dec 30, 2025
4 Insider transaction Dec 30, 2025 Dec 30, 2025
4 Insider transaction Dec 30, 2025 Dec 30, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Oct 1, 2025 —
4 Insider transaction Oct 1, 2025 Sep 29, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 12, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 9, 2025 —
4 Insider transaction Apr 28, 2025 Apr 24, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Apr 2, 2025 —
4 Insider transaction Apr 2, 2025 Mar 31, 2025
SCHEDULE 13G Ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Feb 11, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Jan 3, 2025 —
3 Initial insider ownership Jan 3, 2025 Dec 31, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
3 Initial insider ownership Oct 29, 2024 Oct 23, 2024
SC 13D/A Amended ownership over 5% (active) Jun 28, 2024 —
4 Insider transaction Jun 28, 2024 Jun 27, 2024
4 Insider transaction Jun 4, 2024 May 31, 2024
4 Insider transaction Jun 4, 2024 Apr 24, 2022
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
3 Initial insider ownership Feb 12, 2024 Jan 19, 2024
4 Insider transaction Jan 3, 2024 Jan 2, 2024
3 Initial insider ownership Dec 19, 2023 Dec 11, 2023
4 Insider transaction Jul 7, 2023 Jul 5, 2023
4 Insider transaction Jul 7, 2023 Jul 5, 2023
4 Insider transaction Jul 7, 2023 Jul 5, 2023
4 Insider transaction Jul 7, 2023 Jul 5, 2023
4 Insider transaction Jul 7, 2023 Jul 5, 2023
4 Insider transaction Jul 7, 2023 Apr 24, 2023
3/A Ownership document Apr 6, 2023 Sep 26, 2016
3/A Ownership document Apr 6, 2023 Sep 26, 2016
4 Insider transaction Apr 3, 2023 Mar 18, 2022
4 Insider transaction Apr 3, 2023 Mar 18, 2022
4 Insider transaction Apr 3, 2023 Jul 29, 2022
4 Insider transaction Apr 3, 2023 Jul 29, 2022
4 Insider transaction Apr 3, 2023 Jul 29, 2022
4 Insider transaction Apr 3, 2023 Jul 29, 2022
SC 13D/A Amended ownership over 5% (active) Jan 13, 2023 —
4 Insider transaction Jan 6, 2023 Jan 6, 2023
SC 13G Ownership over 5% (passive) Jul 8, 2022 —
3 Initial insider ownership Jun 7, 2022 Apr 18, 2022
SC 13G Ownership over 5% (passive) Feb 4, 2022 —
4 Insider transaction Dec 16, 2021 Dec 8, 2021
4 Insider transaction Nov 8, 2021 Oct 27, 2021
4 Insider transaction Oct 21, 2021 Oct 12, 2021
4 Insider transaction Sep 24, 2021 Aug 31, 2021
4 Insider transaction Sep 24, 2021 Aug 31, 2021
4 Insider transaction Aug 5, 2021 Jul 30, 2021
4 Insider transaction Jul 8, 2021 Jun 28, 2021
4 Insider transaction Jul 8, 2021 Jun 28, 2021
4 Insider transaction Jul 8, 2021 Jun 28, 2021
4 Insider transaction Jul 8, 2021 Jun 17, 2021
4 Insider transaction Jul 8, 2021 Jun 28, 2021
4 Insider transaction Jul 8, 2021 Jun 28, 2021
4 Insider transaction Apr 29, 2021 May 22, 2020
4 Insider transaction Apr 16, 2021 Dec 6, 2019
SC 13G/A Amended ownership over 5% (passive) Apr 12, 2021 —
4 Insider transaction Mar 15, 2021 Feb 26, 2021
4 Insider transaction Mar 15, 2021 Feb 26, 2021
4 Insider transaction Mar 15, 2021 Dec 15, 2020
SC 13G Ownership over 5% (passive) Feb 2, 2021 —
4/A Form 4/a Dec 22, 2020 Aug 31, 2020
4/A Form 4/a Dec 22, 2020 Feb 28, 2020
4 Insider transaction Dec 22, 2020 Aug 31, 2020
4 Insider transaction Dec 15, 2020 Dec 14, 2020
4 Insider transaction Aug 19, 2020 Jul 14, 2020
4 Insider transaction Aug 19, 2020 Jul 14, 2020
4 Insider transaction Aug 19, 2020 Jul 14, 2020
4 Insider transaction Aug 19, 2020 Jul 14, 2020
4 Insider transaction Aug 19, 2020 Jul 14, 2020
4 Insider transaction Jun 15, 2020 Jun 11, 2020
4 Insider transaction May 22, 2020 May 14, 2020
4 Insider transaction Apr 29, 2020 Mar 5, 2020
4 Insider transaction Apr 29, 2020 Mar 5, 2020
3 Initial insider ownership Apr 29, 2020 Jun 7, 2017
4 Insider transaction Jan 17, 2020 Apr 16, 2019
4 Insider transaction Jan 17, 2020 Aug 28, 2019
4 Insider transaction Jan 17, 2020 Aug 28, 2019
4 Insider transaction Jan 17, 2020 Jun 14, 2018
4 Insider transaction Jan 17, 2020 Aug 28, 2019
4/A Form 4/a Jan 17, 2020 Jun 14, 2018
SC 13D/A Amended ownership over 5% (active) May 17, 2019 —
4 Insider transaction Dec 18, 2018 Nov 20, 2018
4 Insider transaction Dec 7, 2018 Jun 14, 2018
4 Insider transaction Dec 3, 2018 Feb 2, 2018
3 Initial insider ownership Nov 27, 2018 Nov 14, 2017
4 Insider transaction Nov 13, 2018 Jun 14, 2018
4 Insider transaction Nov 5, 2018 Nov 2, 2018
3/A Form 3/a Jul 20, 2017 Sep 26, 2016
3/A Form 3/a Jul 20, 2017 Jun 7, 2017
3 Initial insider ownership Jul 20, 2017 Sep 26, 2016
3 Initial insider ownership Jun 30, 2017 Sep 26, 2016
3 Initial insider ownership Jun 30, 2017 Apr 24, 2017
3 Initial insider ownership Jun 30, 2017 Sep 26, 2016
3 Initial insider ownership Jun 30, 2017 Jun 7, 2017
3 Initial insider ownership Jun 30, 2017 Sep 26, 2016
4 Insider transaction Jun 7, 2017 Sep 30, 2016
3 Initial insider ownership Jun 7, 2017 Sep 26, 2016
SC 13D Ownership over 5% (active) May 26, 2017 —
SC 13G Ownership over 5% (passive) Feb 14, 2017 —

Showing 105 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
MBIO (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Waltham, MA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1680048

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.